search
Penn Medicine
Trends
- 1OpenEvidence partners with Anthropic and Penn Medicine to expand AI in Africa and Asia●OpenEvidence partners with Anthropic, Penn Medicine to expand physician access to AI across Africa and Asia
Medical AI company OpenEvidence announced a partnership with Anthropic and Penn Medicine to expand physician access to its AI tools across Africa and Asia. The collaboration aims to bring clinical decision-support technology to doctors in regions where access to advanced medical resources is limited. The announcement, reported by Fierce Healthcare, highlights growing efforts to deploy AI in global health, though details on funding and rollout timelines have not been disclosed.
- 2Penn Medicine and IBA Launch Global Proton Therapy Venture▼Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
Penn Medicine and Belgian proton therapy company IBA have announced a joint venture to support the development of proton therapy and radiation oncology programs worldwide. The partnership aims to help hospitals and clinics internationally establish and expand advanced cancer treatment services, combining Penn Medicine's clinical expertise with IBA's technology. The announcement has been picked up by financial and international news outlets.
- 3Severe withdrawal cases signal rising medetomidine use●Severe withdrawal cases point to growing medetomidine use
Clinicians at Penn Medicine report a growing number of patients experiencing severe withdrawal symptoms linked to medetomidine, a sedative increasingly found in the illicit drug supply. Health experts warn the drug may be mixed with opioids like fentanyl, complicating treatment and making withdrawal harder to manage than typical opioid dependence.
- 4Penn Medicine and IBA Launch Proton Therapy Joint Venture▼Penn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian proton therapy firm IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will focus on developing and expanding access to advanced radiation treatments for cancer patients. Announced via trade press coverage in medical imaging and technology outlets, the collaboration is being watched for its potential impact on cancer care delivery.
- 5IBA and Penn Medicine Launch Noventra Oncology Alliance▼IBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
IBA and Penn Medicine have announced a joint venture called the Noventra Oncology Alliance, combining the particle therapy technology company's expertise with the academic medical center's clinical and research capabilities. The partnership is aimed at advancing cancer treatment, though further details about its scope, funding and first projects have not yet been made widely available.
- 6Penn Medicine plans new surgery centers in Delaware●Penn Medicine expands Delaware push with planned surgery centers
Penn Medicine is expanding its presence in Delaware with plans to open new surgery centers, according to the Delaware Business Times. The move extends the health system's growing footprint in the state, adding outpatient surgical capacity for local patients. The announcement reflects a broader trend of major hospital systems investing in ambulatory surgical facilities outside their home markets.